Skip to main content
Erschienen in: Herz 7/2020

05.12.2018 | Original articles

Decreased platelet-to-lymphocyte ratio as predictor of thrombogenesis in nonvalvular atrial fibrillation

verfasst von: K. Zuo, MD, X. Yang, MD

Erschienen in: Herz | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Inflammation plays a key role in the progression of atrial fibrillation and its related prothrombotic state. The platelet-to-lymphocyte ratio (PLR) is an easily obtainable biomarker of inflammatory burden. Decreased left atrial appendage flow velocity (LAA-FV) reflects blood stasis, and left atrial strain is a manifestation of atrial remodeling. This study examined the role of PLR in reflecting decreased LAA-FV and its correlation with impaired left atrial strain.

Methods

In 54 patients with nonvalvular atrial fibrillation, LAA-FV and left atrial strain were measured by echocardiography. The PLR was calculated from a complete blood count.

Results

The PLR was lower in the group of patients with decreased LAA-FV (84.22 [IQR, 69.87–98.17 cm/s] vs. 103.27 [IQR, 90.37–127.16 cm/s]; p = 0.018). PLR was predictive of decreased LAA-FV with a sensitivity of 66.7% and a specificity of 83.3%. In a receiver operator characteristic curve analysis, using a cut-off value of 88.16, the area under the curve for PLR as a predictor of decreased LAA-FV was 0.726 (p = 0.018). Furthermore, the patients with a PLR of < 88.16 had a lower left atrial strain than those with a PLR of > 88.16 (0.38 vs. 0.77, p = 0.02).

Conclusion

The PLR was lower in patients with nonvalvular atrial fibrillation and with a decreased LAA-FV. Its correlation with left atrial strain might indicate the role of inflammation in the progression of atrial remodeling and in the prothrombotic state.
Literatur
1.
Zurück zum Zitat Van den Berg MP, van Gelder IC, van Veldhuisen DJ (2002) Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 4:571–575PubMed Van den Berg MP, van Gelder IC, van Veldhuisen DJ (2002) Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 4:571–575PubMed
2.
Zurück zum Zitat Delgado V, Di Biase L, Leung M et al (2017) Structure and function of the left atrium and left atrial appendage. J Am Coll Cardiol 70:3157–3172PubMed Delgado V, Di Biase L, Leung M et al (2017) Structure and function of the left atrium and left atrial appendage. J Am Coll Cardiol 70:3157–3172PubMed
3.
Zurück zum Zitat Klesen A, Jakob D, Emig R, Kohl P, Ravens U, Peyronnet R (2018) Cardiac fibroblasts active players in (atrial) electrophysiology? Herzschrittmacherther Elektrophysiol 29(1):62–69PubMed Klesen A, Jakob D, Emig R, Kohl P, Ravens U, Peyronnet R (2018) Cardiac fibroblasts active players in (atrial) electrophysiology? Herzschrittmacherther Elektrophysiol 29(1):62–69PubMed
4.
Zurück zum Zitat Lee JM, Shim J, Uhm J‑S (2014) Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation. Am J Cardiol 113:963–969PubMed Lee JM, Shim J, Uhm J‑S (2014) Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation. Am J Cardiol 113:963–969PubMed
5.
Zurück zum Zitat Pagola J, González-Alujas T, Flores A et al (2014) Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes. Stroke 45(8):164–166 Pagola J, González-Alujas T, Flores A et al (2014) Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes. Stroke 45(8):164–166
7.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16(3):233–270PubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16(3):233–270PubMed
8.
Zurück zum Zitat Zuo K, Sun L, Yang X, Lyu X, Li K (2017) Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA2DS2-VASc score: study based on transesophageal echocardiography and 2‑dimensional speckle tracking. Clin Cardiol 40(2):120–125PubMedPubMedCentral Zuo K, Sun L, Yang X, Lyu X, Li K (2017) Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA2DS2-VASc score: study based on transesophageal echocardiography and 2‑dimensional speckle tracking. Clin Cardiol 40(2):120–125PubMedPubMedCentral
9.
Zurück zum Zitat Vianna-Pinton R, Moreno CA, Baxter CM, Lee KS, Tsang TS, Appleton CP (2009) Two-dimensional speckle-tracking echocardiography of the left atrium. Feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 22:299–305PubMed Vianna-Pinton R, Moreno CA, Baxter CM, Lee KS, Tsang TS, Appleton CP (2009) Two-dimensional speckle-tracking echocardiography of the left atrium. Feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 22:299–305PubMed
10.
Zurück zum Zitat Pollick C, Taylor D (1991) Assessment of left trial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 84:223–231PubMed Pollick C, Taylor D (1991) Assessment of left trial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 84:223–231PubMed
11.
Zurück zum Zitat Zabalgoitia M, Halperin J, Pearce LA, Blackshear JL, Asinger RW, Hart RG (1998) Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol 31:1622–1626PubMed Zabalgoitia M, Halperin J, Pearce LA, Blackshear JL, Asinger RW, Hart RG (1998) Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol 31:1622–1626PubMed
12.
Zurück zum Zitat Shiroshita-Takeshita A, Brundel BJJM, Nattel S (2005) Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 13:181–193PubMed Shiroshita-Takeshita A, Brundel BJJM, Nattel S (2005) Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 13:181–193PubMed
13.
Zurück zum Zitat King JB, Azadani PN, Suksaranjit P et al (2017) Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation. J Am Coll Cardiol 70:1311–1321PubMed King JB, Azadani PN, Suksaranjit P et al (2017) Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation. J Am Coll Cardiol 70:1311–1321PubMed
14.
Zurück zum Zitat Zghaib T, Keramati A, Chrispin J et al (2018) Multimodal examination of atrial fibrillation substrate correlation of left atrial bipolar voltage using multi-electrode fast automated mapping, point-by-point mapping, and magnetic resonance image intensity ratio. JACC Clin Electrophysiol 4(1):59–68PubMed Zghaib T, Keramati A, Chrispin J et al (2018) Multimodal examination of atrial fibrillation substrate correlation of left atrial bipolar voltage using multi-electrode fast automated mapping, point-by-point mapping, and magnetic resonance image intensity ratio. JACC Clin Electrophysiol 4(1):59–68PubMed
15.
Zurück zum Zitat Marrouche NF, Wilber D, Hindricks G et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311(5):498–506PubMed Marrouche NF, Wilber D, Hindricks G et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311(5):498–506PubMed
17.
Zurück zum Zitat Kadappu KK, Abhayaratna K, Boyd A et al (2016) Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: the value of left atrial function and volume. J Am Soc Echocardiogr 29:359–367PubMed Kadappu KK, Abhayaratna K, Boyd A et al (2016) Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: the value of left atrial function and volume. J Am Soc Echocardiogr 29:359–367PubMed
18.
Zurück zum Zitat Fukushima K, Fukushima N, Kato K et al (2016) Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging 17:59–66PubMed Fukushima K, Fukushima N, Kato K et al (2016) Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging 17:59–66PubMed
19.
Zurück zum Zitat Conway DS, Buggins P, Hughes E, Lip GY (2004) Relationship of interleukin-6 and C‑reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43:2075–2082PubMed Conway DS, Buggins P, Hughes E, Lip GY (2004) Relationship of interleukin-6 and C‑reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43:2075–2082PubMed
20.
Zurück zum Zitat Lip GY, Patel JV, Hughes E, Hart RG (2007) High-sensitivity C‑ reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38:1229–1237PubMed Lip GY, Patel JV, Hughes E, Hart RG (2007) High-sensitivity C‑ reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38:1229–1237PubMed
21.
Zurück zum Zitat Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8 Suppl):C7–C12PubMed Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8 Suppl):C7–C12PubMed
22.
Zurück zum Zitat Temiz A, Gazi E, Güngör Ö et al (2014) Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 20:660–665PubMedPubMedCentral Temiz A, Gazi E, Güngör Ö et al (2014) Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 20:660–665PubMedPubMedCentral
23.
Zurück zum Zitat Smyth SS, McEver RP, Weyrich AS et al (2009) Platelet functions beyond hemostasis. J Thromb Haemost 7:1759–1766PubMed Smyth SS, McEver RP, Weyrich AS et al (2009) Platelet functions beyond hemostasis. J Thromb Haemost 7:1759–1766PubMed
24.
Zurück zum Zitat Henn V, Slupsky JR, Gräfe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594PubMed Henn V, Slupsky JR, Gräfe M et al (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594PubMed
25.
Zurück zum Zitat Langer HF, Gawaz M (2008) Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 99:480–486PubMed Langer HF, Gawaz M (2008) Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 99:480–486PubMed
26.
Zurück zum Zitat Kurtul A, Yarlioglues M, Murat S et al (2014) Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol 114:342–347PubMed Kurtul A, Yarlioglues M, Murat S et al (2014) Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol 114:342–347PubMed
27.
Zurück zum Zitat Azab B, Shah N, Akerman M, McGinn JT Jr (2012) Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 34:326–334PubMed Azab B, Shah N, Akerman M, McGinn JT Jr (2012) Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 34:326–334PubMed
Metadaten
Titel
Decreased platelet-to-lymphocyte ratio as predictor of thrombogenesis in nonvalvular atrial fibrillation
verfasst von
K. Zuo, MD
X. Yang, MD
Publikationsdatum
05.12.2018
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 7/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-018-4770-7

Weitere Artikel der Ausgabe 7/2020

Herz 7/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.